Differences in Functional Level and Central Symptom of Network Structures in the Patients Seeking Treatment for Panic Disorder Before and During the COVID-19 Pandemic.

COVID-19 Functional impairment Interoceptive fear Network analysis Panic disorder

Journal

Psychiatry investigation
ISSN: 1738-3684
Titre abrégé: Psychiatry Investig
Pays: Korea (South)
ID NLM: 101242994

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 03 11 2022
accepted: 25 12 2022
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: ppublish

Résumé

Mental health problems such as anxiety, panic, and depression have been exacerbated by the coronavirus disease-2019 (COVID-19). This study aimed to compare the symptom severities and overall function before and during the COVID-19 pandemic among patients with panic disorder (PD) seeking treatment compared to healthy controls (HCs). Baseline data were collected from the two groups (patients with PD and HCs) in two separate periods: before COVID-19 (Jan 2016-Dec 2019) and during COVID-19 (Mar 2020-Jul 2022). A total 453 participants (before COVID-19: 246 [139 patients with PD and 107 HCs], during COVID-19: 207 [86 patients with PD and 121 HCs]) was included. Scales for panic and depressive symptoms and overall function were administered. Additionally, network analyses were performed to compare the two groups within the patients with PD. The results of two-way analysis of variance analyses showed that patients with PD enrolled during COVID-19 showed higher levels of interoceptive fear and lower overall functioning. In addition, a network comparison test revealed that a significantly high strength and expected influence for agoraphobia and avoidance in patients with PD during COVID-19. This study suggested that the overall function could have worsened, and the importance of agoraphobia and avoidance as a central symptom may have increased in patients with PD seeking treatment during COVID-19.

Identifiants

pubmed: 36990668
pii: pi.2022.0318
doi: 10.30773/pi.2022.0318
pmc: PMC10064207
doi:

Types de publication

Journal Article

Langues

eng

Pagination

245-254

Subventions

Organisme : National Research Foundation of Korea
ID : 2019M3C7A1032262
Organisme : National Research Foundation of Korea
ID : 2021M3E5D9025026
Organisme : Ministry of Science and ICT
Organisme : National IT Industry Promotion Agency
ID : S0254-22-1002

Références

Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Psychol Methods. 2022 Apr 11;:
pubmed: 35404628
Cognit Ther Res. 2020;44(6):1043-1051
pubmed: 32904454
Psychol Methods. 2018 Dec;23(4):617-634
pubmed: 29595293
Brain Behav Immun. 2020 Jul;87:34-39
pubmed: 32298803
Behav Res Ther. 2005 Mar;43(3):337-55
pubmed: 15680930
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
J Pain Symptom Manage. 2021 Apr;61(4):e1-e4
pubmed: 33476753
Arch Gen Psychiatry. 1994 May;51(5):346-54
pubmed: 8179458
Transl Psychiatry. 2022 Mar 10;12(1):98
pubmed: 35273161
J Anxiety Disord. 1998 Sep-Oct;12(5):463-83
pubmed: 9801964
Behav Res Methods. 2018 Feb;50(1):195-212
pubmed: 28342071
Depress Anxiety. 2007;24(5):331-41
pubmed: 17041921
Epidemiol Health. 2022;44:e2022018
pubmed: 35057582
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
Soc Psychol Personal Sci. 2017 Jul;8(5):528-537
pubmed: 28919944
Soc Psychiatry Psychiatr Epidemiol. 1992 Mar;27(2):78-82
pubmed: 1594977
Prim Care Companion CNS Disord. 2020 Apr 30;22(3):
pubmed: 32369687
Int J Psychiatry Med. 1997;27(2):93-105
pubmed: 9565717
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(6):128-133
pubmed: 35758958
Exp Ther Med. 2020 Jul;20(1):159-162
pubmed: 32509006
Healthcare (Basel). 2021 Jun 03;9(6):
pubmed: 34204925
J Affect Disord. 2021 Nov 1;294:753-760
pubmed: 34375200
Exp Ther Med. 2021 Mar;21(3):244
pubmed: 33603852

Auteurs

Hyun-Ju Kim (HJ)

Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.

Minji Bang (M)

Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.

Chun Il Park (CI)

Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.

Chongwon Pae (C)

Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.

Sang-Hyuk Lee (SH)

Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.

Classifications MeSH